These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37045459)

  • 1. Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis.
    Aldarwish WA; Ali EN
    Neurosciences (Riyadh); 2023 Apr; 28(2):148-150. PubMed ID: 37045459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
    Sammaraiee Y; Yardley M; Keenan L; Buchanan K; Stevenson V; Farrell R
    Mult Scler Relat Disord; 2019 Jan; 27():95-100. PubMed ID: 30366276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal Baclofen Therapy in Patients With Multiple Sclerosis: Improved Outcomes and Reduced Costs Through Identification of Catheter Malfunction.
    Nelson MES; McGuire JR
    Neuromodulation; 2019 Oct; 22(7):839-842. PubMed ID: 31157471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the cognitive benefits of intrathecal baclofen pump implantation in people with intractable multiple sclerosis related spasticity.
    Farrell R; Summers M; Doogan C; Mulhert N; Keenan E; Buchanan K; Lee H; Padilla H; Stevenson VL
    Mult Scler Relat Disord; 2021 May; 50():102831. PubMed ID: 33618123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.
    Sammaraiee Y; Stevenson VL; Keenan E; Buchanan K; Lee H; Padilla H; Farrell RA
    Mult Scler Relat Disord; 2020 Nov; 46():102503. PubMed ID: 33032053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.
    Stampacchia G; Gerini A; Mazzoleni S
    NeuroRehabilitation; 2016 Apr; 38(4):385-93. PubMed ID: 27061166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.
    Rekand T; Grønning M
    J Rehabil Med; 2011 May; 43(6):511-4. PubMed ID: 21533331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients.
    Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B
    Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of intrathecal baclofen pump in primary lateral sclerosis.
    Zubair AS; Raymond M; Patwa HS
    J Neurol Sci; 2021 Jan; 420():117227. PubMed ID: 33239209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal baclofen for muscle spasticity and pain--two case reports.
    Al Khudhairi D; Rababa A; Saddiqui MN
    Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of spasticity in multiple sclerosis by intrathecal baclofen.
    Dario A; Tomei G
    Acta Neurochir Suppl; 2007; 97(Pt 1):189-92. PubMed ID: 17691376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early outcomes after intrathecal baclofen therapy in ambulatory patients with multiple sclerosis.
    Lee BS; Jones J; Lang M; Achey R; Dai L; Lobel DA; Nagel SJ; Machado AG; Bethoux F
    J Neurosurg; 2018 Oct; 129(4):1056-1062. PubMed ID: 29192855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical worsening of spasticity and pain in the lower extremities after increasing the dose of intrathecal baclofen--case report.
    Murakami M; Hirata Y; Kuratsu J
    Neuromodulation; 2012; 15(1):39-40; discussion 41. PubMed ID: 22151599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of severe spacticity in multiple sclerosis by continuous intrathecal baclofen].
    Perić P; Antić B; Dincić E; Obradović D; Arsić S
    Vojnosanit Pregl; 2006 Feb; 63(2):187-91. PubMed ID: 16502996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
    Bensmail D; Quera Salva MA; Roche N; Benyahia S; Bohic M; Denys P; Bussel B; Lofaso F
    Neurology; 2006 Oct; 67(8):1432-6. PubMed ID: 17060570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal baclofen in multiple sclerosis and spinal cord injury: complications and long-term dosage evolution.
    Draulans N; Vermeersch K; Degraeuwe B; Meurrens T; Peers K; Nuttin B; Kiekens C
    Clin Rehabil; 2013 Dec; 27(12):1137-43. PubMed ID: 23858524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
    Stetkarova I; Brabec K; Vasko P; Mencl L
    Pain Physician; 2015; 18(4):E633-41. PubMed ID: 26218954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal baclofen for spasticity in primary lateral sclerosis.
    Milano JB; Neto MC; Hunhevicz SC; Arruda WO; Ramina R; Barros E
    J Neurol; 2005 Jun; 252(6):740-1. PubMed ID: 15789133
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.
    Abbatemarco JR; Griffin A; Jones NG; Hartman J; McKee K; Wang Z; Nagel SJ; Machado AG; Bethoux F
    Mult Scler; 2021 May; 27(6):933-941. PubMed ID: 32662728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.